持续性急性损伤生物标志物:系统性审查和元分析
概括
尿中C-C基因基因14 (CCL14) 是预测持续急性损伤 (AKI) 的最准确的生物标志物,特别是在2-3-3阶段. 这一元分析比较了各种人群和地区的七种生物标志物,证实了CCL14的存在.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 生物标志物发现发现
- 诊断的准确性 诊断的准确性
背景情况:
- 持续的急性损伤 (AKI) 是一个重大的临床挑战.
- 预测持续性AKI的现有生物标志物显示出可变的性能.
- 需要准确可靠的生物标志物来识别患有持续性AKI风险的患者.
研究的目的:
- 为了比较各种生物标志物的诊断准确性来预测持续性AKI.
- 评估不同人口和地理区域生物标志物的表现.
- 确定预测持续性AKI的最佳生物标志物.
主要方法:
- 在Medline,PubMed,Embase和Cochrane数据库中发表的研究的综合元分析.
- 包括评估尿C-C动机化学联体14 (CCL14),金属蛋白酶-2和胰岛素样生长因子结合蛋白-7 (TIMP-2&IGFBP7) 的组织抑制剂,中性纤维糖酶相关脂 (NGAL),血囊C (pCysC) 等研究.
- 使用分层总结主题工作特征曲线 (HSROC) 和诊断几率比 (DOR) 进行准确性评估.
- 进行了元回归和子组分析,以探索异质性并确定表现最佳的生物标志物.
主要成果:
- CCL14显示了持续性AKI的最高整体诊断疗效,AUC为0.79.
- TIMP-2&IGFBP7,NGAL和pCysC的预测值均为中等 (AUC分别为0.75,0.71和0.70).
- 亚组分析表明CCL14在重症监护室,败血症和术后患者群体以及不同地区的优异表现. CCL14最有效地预测了持续的2-3期AKI.
结论:
- 尿路CCL14被认为是预测持续性AKI最准确的生物标志物.
- CCL14在各种临床环境和人群中表现出一致的预测性能.
- 这些发现支持CCL14在临床实践中用于早期识别持续的AKI风险.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
121
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
121
Factors Affecting Renal Clearance: Renal Impairment
68
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
68
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
69
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69
Renal Failure: Dose Adjustments
77
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
77


